Asian Myeloproliferative Neoplasm (MPN) Registry

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorThe University of Hong Kong

About this trial

This is a multinational, multicenter, prospective and retrospective, observational, cohort study of patients with myeloproliferative neoplasm.

Age ≥ 18 years old at the time of diagnosis of MPN.

Polycythaemia vera

Essential thrombocythemia

Primary myelofibrosis, pre-fibrotic/early stage

None

No trial groups listed

Department of Medicine, Queen Mary Hospital Hong Kong Hong Kong

The University of Hong Kong

Lead sponsor

Novartis

Collaborator